Codexis (CDXS) Common Equity (2010 - 2026)
Codexis (CDXS) recorded quarterly Common Equity of $43.2 million in Q1 2026, down 14.44% quarter-over-quarter from $50.5 million in Q4 2025, and down 12.89% on a YoY basis from $49.6 million in Q1 2025.
Codexis (CDXS) Common Equity (2010 - 2026) Analysis & Trends
Codexis' Common Equity history runs 17 years deep, the most recent figure standing at $43.2 million for Q1 2026.
- In Q1 2026, Common Equity fell 12.89% year-over-year to $43.2 million; the TTM figure through Mar 2026 stood at $43.2 million (down 12.89% YoY), while the FY2025 annual figure was $50.5 million, down 24.5% from the prior year.
- Common Equity was $43.2 million for Q1 2026 at Codexis, down from $50.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $159.5 million in Q2 2022 to a low of $38.5 million in Q3 2025.
- Historically, Common Equity has averaged $92.0 million across 5 years, with a median of $79.3 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Common Equity slipped 2.04% in 2022, then sank 50.5% in 2024.
- A 5-year view of Common Equity shows it stood at $144.8 million in 2022, then tumbled by 40.18% to $86.6 million in 2023, then dropped by 22.73% to $66.9 million in 2024, then retreated by 24.5% to $50.5 million in 2025, then retreated by 14.44% to $43.2 million in 2026.
- The last three Common Equity figures came in at $43.2 million (Q1 2026), $50.5 million (Q4 2025), and $38.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 43.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.23 Mn |
| Dec 31, 2025 | 50.53 Mn |
| Sep 30, 2025 | 38.54 Mn |
| Jun 30, 2025 | 55.63 Mn |
| Mar 31, 2025 | 49.63 Mn |
| Dec 31, 2024 | 66.93 Mn |
| Sep 30, 2024 | 73.40 Mn |
| Jun 30, 2024 | 61.45 Mn |
| Mar 31, 2024 | 79.27 Mn |
| Dec 31, 2023 | 86.62 Mn |
| Sep 30, 2023 | 91.51 Mn |
| Jun 30, 2023 | 124.13 Mn |
| Mar 31, 2023 | 126.02 Mn |
| Dec 31, 2022 | 144.80 Mn |
| Sep 30, 2022 | 154.13 Mn |
| Jun 30, 2022 | 159.46 Mn |
| Mar 31, 2022 | 158.64 Mn |
| Dec 31, 2021 | 164.39 Mn |
| Sep 30, 2021 | 169.06 Mn |
| Jun 30, 2021 | 162.77 Mn |